BioSyent Inc.
BIOYF
$7.57
$0.20952.85%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 25.56M | 25.36M | 24.97M | 24.36M | 23.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.56M | 25.36M | 24.97M | 24.36M | 23.42M |
| Cost of Revenue | 5.24M | 5.22M | 5.05M | 4.77M | 4.44M |
| Gross Profit | 20.32M | 20.14M | 19.92M | 19.59M | 18.97M |
| SG&A Expenses | 17.30M | 14.06M | 13.76M | 13.53M | 13.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.72M | 19.28M | 18.81M | 18.31M | 17.87M |
| Operating Income | 8.13M | 6.08M | 6.16M | 6.05M | 5.54M |
| Income Before Tax | 7.15M | 6.90M | 7.00M | 6.93M | 6.33M |
| Income Tax Expenses | 1.83M | 1.68M | 1.72M | 1.70M | 1.54M |
| Earnings from Continuing Operations | 5.31 | 5.23 | 5.29 | 5.24 | 4.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.31M | 5.23M | 5.29M | 5.24M | 4.79M |
| EBIT | 8.13M | 6.08M | 6.16M | 6.05M | 5.54M |
| EBITDA | 8.69M | 6.32M | 6.42M | 6.33M | 5.85M |
| EPS Basic | 0.46 | 0.45 | 0.45 | 0.44 | 0.40 |
| Normalized Basic EPS | 0.49 | 0.37 | 0.37 | 0.37 | 0.33 |
| EPS Diluted | 0.45 | 0.44 | 0.44 | 0.43 | 0.39 |
| Normalized Diluted EPS | 0.48 | 0.36 | 0.37 | 0.36 | 0.33 |
| Average Basic Shares Outstanding | 46.34M | 46.65M | 46.90M | 47.37M | 47.80M |
| Average Diluted Shares Outstanding | 47.20M | 47.50M | 47.73M | 48.21M | 48.68M |
| Dividend Per Share | 0.13 | 0.13 | 0.13 | 0.12 | 0.12 |
| Payout Ratio | 28.59% | 28.69% | 27.80% | 27.67% | 29.58% |